| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.23 | 3e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |